ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

CEO

Karyawan

Negara

Amerika Serikat

ISIN

US04522R1014

WKN

000A3D7BB

Pencatatan

7A9.MU

0 Comments

Bagikan pendapatmu

FAQ

Apa simbol saham ASLAN Pharmaceuticals?▼

Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa Boerse Muenchen, saham ASLAN Pharmaceuticals diperdagangkan dengan simbol 7A9.MU.

Berapa jumlah karyawan ASLAN Pharmaceuticals?▼

Per September 05, 2026, perusahaan memiliki 35 karyawan.

ASLAN Pharmaceuticals berada di sektor apa?▼

ASLAN Pharmaceuticals beroperasi di sektor Teknologi.

Kapan ASLAN Pharmaceuticals menyelesaikan split saham?▼

ASLAN Pharmaceuticals belum melakukan split saham baru-baru ini.

Di mana kantor pusat ASLAN Pharmaceuticals?▼

Kantor pusat ASLAN Pharmaceuticals berlokasi di 190 Elgin Avenue, Amerika Serikat.